Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
August 27, 2024 08:01 ET
|
Ocean Biomedical, Inc.
Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that its Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been issued a key U.S. patent for...
Nobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble Gases
June 12, 2017 18:57 ET
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 12, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics announced today that the patent that it had exclusively licensed from Partners HealthCare/McLean Hospital (an affiliate of...
Vapir Enterprises, Inc. Is Granted Its Sixth U.S. Patent
December 07, 2015 05:00 ET
|
Vapir Enterprises, Inc.
San Jose, CA, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Vapir Enterprises, Inc. (OTCQB: VAPI) (www.vapir.com) (“Vapir” or the “Company”), a developer and manufacturer of revolutionary, state-of-the-art, and...